MDCG explains when devices can be exempt from the premarket clinical evaluation consultation procedure |

Article 54(2) of the MDR lays down three criteria that exempt devices from the premarket clinical evaluation consultation procedure with the involvement of expert panels.

https://ec.europa.eu/docsroom/documents/40661?locale=en